CytoTherapeutics deal

CTII and the Akzo Faser Ag, Business Unit Membrana of Akzo formed an exclusive alliance to develop and manufacture membranes for cell-containing devices that can be implanted to treat central nervous system diseases and other chronic disorders. CTII will have sole access to all of Membrana's existing and novel membranes for cell and gene therapy. CTII also will maintain its own membrane development and manufacturing programs. ...